Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotic Market
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotic Market Size, Share & Trends Analysis Report By Treatment Type (Vancomycin, Tetracycline, Linezolid, Daptomycin, and Lipopeptide), and By Distribution Channel (Online, Hospital Pharmacies, and Retail Pharmacies) Forecast 2022-2028
The MRSA antibiotic market is expected to grow at a significant CAGR of 5.5% during the forecast period. The increase in the MRSA infections and a rise in the immuno-compromised population are expected to enhance the market growth. According to the information highlighted by the centers for diseases control and prevention (CDC), in 2019, 2% of the general population carries MRSA. Moreover, As per the findings from a six-month, hospital-based observational study provided by the American Journal of Infection Control (AJIC), in August 2021, new data suggest that methicillin-resistant Staphylococcus aureus (MRSA) is frequently shed during outpatient healthcare visits, creating the potential for transmission to other patients and healthcare staff. This is considered as the first empirical data regarding the frequency of and risk factors for MRSA contamination outside hospital rooms.
Further, MRSA antibiotics have been gaining significant growth in recent years owing to the rising awareness about MRSA infection. For instance, globally MRSA awareness day is celebrated in October and antibiotic awareness day on November 18 in Europe. Additionally, the MRSA antibiotic market fragmented with players such as Pfizer, Lilly, Sanofi Aventis, and Merck that are contributing significantly to the market.
Impact of COVID-19 Pandemic on Global MRSA antibiotic Market
The COVID-19 pandemic had impacted the global economy due to a slowdown in the manufacturing of various industries. MRSA antibiotic market also got adversely affected due to lockdown restrictions across the globe. All the industries were closed and also transportation system got also affected. However, due to the rising incidence of COVID-19, major companies in the global MRSA antibiotic market have started their focus on research and development to enhance and counteract COVID-19’s effects.
Segmental Outlook
The MRSA antibiotic market is segmented based on the treatment type, and distribution channel. Based on the treatment type, the market is segmented into vancomycin, tetracyclines, linezolid, daptomycin, and lipopeptide. Based on distribution channel the market is sub-segmented into online, hospital pharmacies, and retail pharmacies. Among these, the hospital pharmacies distribution channel segment is anticipated to propel the growth of the market over the forecast period. Furthermore, by treatment type lipopeptide hold the market share during the forecast period.
Global MRSA Market Share by Treatment Type, 2021 (%)
The Lipopeptide is Holding a Prominent Share in the Global MRSA antibiotic Market
The lipopeptide segment is holding the major market share owing to the novel antibiotic therapy introduced for MRSA. Furthermore, rapid implementation of therapy is expected to fuel the growth of the market. Moreover, their ability to self-assemble into different structures and strong antifungal and hemolytic activities further drive the segment. In addition, lipopeptide detergents (LPDs) another form of lipopeptide which composed of amphiphiles and two alkyd chains which are located on the last part of the peptide backbone are designed to mimic the architecture of the native membranes is also supporting the segment growth.
Regional Outlooks
The MRSA antibiotic market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America).
Global MRSA Antibiotic Market Growth, by region 2022-2028
North America Region is estimated to Hold the Major Share in the Global MRSA antibiotic Market
North America is anticipated to hold a prominent share in the market mainly due to the investment by companies in the R&D of screening tools for MRSA infection. Additionally, the support from the government to treat MRSA lung infection in individuals with cystic fibrosis has also fueled the market. For instance, in 2018 Cystic Fibrosis Foundation announced that it will spend at least $100 million over the next five years in North America to support improved detection, diagnosis, prevention, and treatment of infection related to cystic fibrosis.
Market Players Outlook
The major companies serving the global MRSA antibiotic market include Merck Group., Pfizer Inc., Viatris Inc., Eli Lilly and Company, Allergan, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in 2019, Paratek pharmaceuticals Inc. launched NUZYRA (omadacycline) in the US for MRSA treatment.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global MRSA antibiotic market. Based on the availability of data, information related to market, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global MRSA Antibiotic Market
• Recovery Scenario of Global MRSA Antibiotic Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Merck Group.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Olon Active Pharmaceutical
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Pfizer Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Viatris Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Eli Lilly and Co.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global MRSA Antibiotic Market by Treatment Type
4.1.1. Vancomycin
4.1.2. Tetracycline
4.1.3. Linezolid
4.1.4. Daptomycin
4.1.5. Lipopeptide
4.2. Global MRSA Antibiotic Market by Distribution Channel
4.2.1. Online
4.2.2. Hospital Pharmacies
4.2.3. Retail Pharmacies
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Allergan Inc.
6.2. Baxter International Inc.
6.3. Cumberland Pharmaceuticals Inc.
6.4. Debiopharm International
6.5. Fresenius Kabi AG
6.6. Innovation Pharmaceuticals Inc.
6.7. Melinta therapeutics Inc.
6.8. Nabriva Therapeutics Plc.
6.9. North China Pharmaceutical Group Corp.
6.10. Novartis International AG
6.11. Paratek Pharmaceuticals Inc.
6.12. Sanofi-Aventis Groupe
6.13. Teva Pharmaceutical Industries Ltd.
6.14. Theravance Biopharma Inc.
6.15. Xellia Pharmaceuticals ApS
6.16. Zhejiang Hisun Pharmaceutical Co., Ltd.
6.17. Zhejiang Medicine Co., Ltd.
1. GLOBAL MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
2. GLOBAL VANCOMYCIN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL TETRACYCLINES MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL LINEZOLID MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL DAPTOMYCIN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL LIPOPEPTIDE MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
8. GLOBAL MRSA ANTIBIOTIC BY ONLINE DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL MRSA ANTIBIOTIC BY HOSPITAL PHARMACIES DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL MRSA ANTIBIOTIC BY RETAIL PHARMACIES DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
14. NORTH AMERICAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
15. EUROPEAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
17. EUROPEAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
21. REST OF THE WORLD MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. REST OF THE WORLD MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL MRSA ANTIBIOTIC MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL MRSA ANTIBIOTIC MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL MRSA ANTIBIOTIC MARKET, 2022-2028 (%)
4. GLOBAL MRSA ANTIBIOTIC MARKET BY TREATMENT TYPE, 2021 VS 2028 (%)
5. GLOBAL VANCOMYCIN MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL TETRACYCLINE MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL LINEZOLID MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL DAPTOMYCIN MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL LIPOPEPTIDE MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL MRSA ANTIBIOTIC MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
11. GLOBAL MRSA ANTIBIOTIC BY ONLINE DISTRIBUTION CHANNEL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL MRSA ANTIBIOTIC BY HOSPITAL PHARMACIES DISTRIBUTION CHANNEL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL MRSA ANTIBIOTIC BY RETAIL PHARMACIES DISTRIBUTION CHANNEL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. US MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
17. UK MRSA ANTIBIOTICMARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
26. SOUTH KOREA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF ASIA-PACIFIC MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
